Genta, Inc (fka GNTAQ)

[fmrick]

FMrick, when you say nothing new, you are far from being correct.
Each abstract is different from any abstract in the past.
# of patients is different, dosage is different, how and when the drug was administered is different, conclusions are different.
So far, so good with Tesetaxel.

Of course they are new ABSTRACTS. That is what you go to scientific conferences for. To release information to the industry in the form of abstracts.

But most of this is old trials information. That is how it works. A trial ends, you make a PR and put the information is your 8K. That releases it to the public. Then the people who did the trial, the scientists who did the work, take the data and publish abstracts for conferences and medical publications.

I'm not knocking Tesetaxel or Genta. I'm just saying there is nothing new there. If you follow the company, read the PRs and 8Ks and 10Qs and 10Ks, you have seen a lot of this information already.

Want proof? Go to the web site and read some of the press releases from 2008-09-10. You will see most of this data. Not all because some of it is so basic (early stage) that it did not warrant a press release.